Global Gastroesophageal Reflux Disease (GERD) Device Market Size, Share, Growth Report 2030

Comentários · 68 Visualizações

The Global Gastroesophageal Reflux Disease (GERD) Device Market size was valued at around USD 2.5 billion in 2024 and is expected to reach USD 3.03 billion in 2030. Along with this, the market is estimated to grow at a CAGR of around 3.24% during the forecast period, i.e., 2025-30.

The Global Gastroesophageal Reflux Disease (GERD) Device Market size was valued at around USD 2.5 billion in 2024 and is expected to reach USD 3.03 billion in 2030. Along with this, the market is estimated to grow at a CAGR of around 3.24% during the forecast period, i.e., 2025-30. According to MarkNtel Advisors Study.

Global Gastroesophageal Reflux Disease (GERD) Device Market Driver:

Alarming Global Burden of GERD – The rising prevalence of gastroesophageal reflux diseases & other gastrointestinal disorders, owing to environmental factors, sedentary habits like excessive fat intake as well as frequent smoking & alcohol consumption, and reduced physical activity, has instigated medical device manufacturers to develop more advanced & effective GERD treatment devices to help patients improve their quality of life. As a result, substantial investments are being made in developing such devices, coupled with the increasing number of clinical trials, which are driving the Gastroesophageal Reflux Disease Devices Market.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/global-gastroesophageal-reflux-disease-device-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures) : https://www.marknteladvisors.com/research-library/global-gastroesophageal-reflux-disease-device-market.html

Global Gastroesophageal Reflux Disease (GERD) Device Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

  • By Product Type
    • Diagnostic Device
      • Monometry System
      • PH Monitoring System
    • Esophagoscopes and Gastroscopes
    • Treatment Devices
      • Ultrasonic Surgical Endostapler
      • Fundoplication Devices
      • Sphincter Augmentation Devices
      • Radio Frequency Ablation Devices
  • By Procedure Type
    • Diagnostic Procedures
    • Fundoplication Procedure
    • Radiofrequency Thermal Ablation
    • Magnetic Sphincter Augmentation
  • By End User
    • Hospital
    • Diagnostic Center
    • Ambulatory Surgical Centers
  • By Device Type
    • MUSE- Medigus Ultrasonic Surgical Endostapler
    • LINX Management System
    • Stretta Therapy
    • Bravo Reflux Testing System
    • Digitapper Reflux Testing System
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Middle East and Africa
    • Asia-Pacific  

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Torax Medical, Inc., Pentax Medical, Medtronics Plc, MediGus Limited, Essai Co, Ltd., Medari Theraputics Inc., Takeda Pharmaceuticals Co. Ltd., Johnson & Johnson Services Inc., Olympus Corporation, Diversatek, Inc and others are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/global-gastroesophageal-reflux-disease-device-market.html

Global Gastroesophageal Reflux Disease (GERD) Device Industry Recent Development:

2024: Ethicon, a Johnson & Johnson MedTech company, announced that the U.S. Food & Drug Administration (FDA) has approved a label update to expand the availability of the LINX™ Reflux Management System to include patients with Barrett’s esophagus (BE) experiencing gastroesophageal reflux disease (GERD) symptoms

2024: Medtronic received the CE Mark for its next-generation Endoflip™ 300 system, an advanced diagnostic tool designed to expedite accurate diagnosis of esophageal motility disorders, conditions often missed or misdiagnosed.

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release

Comentários